Plasma Urotensin II Concentration In Gestational Diabetes


Creative Commons License

HURŞİTOĞLU M., EKİZ A., METE F., OKUTURLAR Y. , KOÇOĞLU H., ÇAKIRCA M., ...More

ARCHIVES OF CLINICAL AND EXPERIMENTAL MEDICINE, vol.2, no.3, pp.66-70, 2017 (Other Refereed National Journals)

  • Publication Type: Article / Article
  • Volume: 2 Issue: 3
  • Publication Date: 2017
  • Doi Number: 10.25000/acem.336837
  • Title of Journal : ARCHIVES OF CLINICAL AND EXPERIMENTAL MEDICINE
  • Page Numbers: pp.66-70

Abstract

Aim: Urotensin II (UII) and its system is implicated in the etiology of many diseases (including diabetes mellitus). We tried in this study to evaluate and compare UII levels in gestational diabetes mellitus (GDM). Methods: Thirty-six pregnant women (15 non-GDM patients consisted group 1 and 21 GDM patients consisted group 2) enrolled in this study. The 3rd group consisted of age matched 22 non pregnant healthy women. Plasma UII levels were determined at the beginning of the study. After 12 weeks of delivery, a second plasma UII was determined from group 1 and 2. Results: Gestational UII levels of both GDM and non-GDM patients were higher than non-pregnant healthy controls (p=0.0001 for both). Both gestational and postpartum UII levels of GDM patients were higher than non-GDM patients but had not reached statistical significance (P≥0.05). Plasma UII concentrations in non-GDM patients significantly decreased after delivery but not in GDM patients (p=0.036 and p≥0.05, respectively) Conclusions: The finding of elevated gestational plasma UII concentrations in GDM patients which did not decrease significantly after delivery (in compare to non-GDM patients) shows that plasma UII levels may have a